References
- Smith TJ. Insights into the role of fibroblasts in human autoimmune diseases. Clin Exp Immunol. 2005;141:388–397.
- Menconi F, Marcocci C, Marinò M. Diagnosis and classification of Graves’ disease. Autoimmun Rev. 2014;13:398–402. doi:https://doi.org/10.1016/j.autrev.2014.01.013.
- Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, et al. Consensus statement of the European Group on Graves’ Orbitopathy (EUGOGO) on management of Graves’ orbitopathy. Thyroid. 2008;18:333–346. doi:https://doi.org/10.1089/thy.2007.0315.
- Eckstein A, Dekowski D, Führer-Sakel D, Berchner-Pfannschmidt U, Esser J. Graves’ ophthalmopathy. Ophthalmologe. 2016;113:349–366. doi:https://doi.org/10.1007/s00347-016-0239-3.
- Ambrosio G, Ferrara G, Vitale R, De Marco R. Visual evoked potentials in patients with Graves’ ophthalmopathy complicated by ocular hypertension and suspect glaucoma or dysthyroid optic neuropathy. Doc Ophthalmol. 2003;106:99–104. doi:https://doi.org/10.1023/A:1022561530782.
- Iao TWU, Rong SS, Ling AN, Brelén ME, Young AL, Chong KKL. Electrophysiological studies in thyroid associated orbitopathy: a systematic review. Sci Rep. 2017;7:12108. doi:https://doi.org/10.1038/s41598-017-11998-0.
- Pérez-Rico C, Rodríguez-González N, Arévalo-Serrano J, Blanco R. Evaluation of multifocal visual evoked potentials in patients with Graves’ orbitopathy and subclinical optic nerve involvement. Doc Ophthalmol. 2012;125:11–19.
- Sen E, Berker D, Elgin U, Tutuncu Y, Ozturk F, Guler S, et al. Comparison of optic disc topography in the cases with Graves’ disease and healthy controls. J Glaucoma. 2012;21:586–589. doi:https://doi.org/10.1097/IJG.0b013e31822e8c4f.
- Chen CL, Bojikian KD, Wen JC, Zhang Q, Xin C, Mudumbai RC, et al. Peripapillary retinal nerve fiber layer vascular microcirculation in eyes with glaucoma and single-hemifield visual field loss. JAMA Ophthalmol. 2017;135:461–468. doi:https://doi.org/10.1001/jamaophthalmol.2017.0261.
- Fard MA, Ghahvechian H, Sahrayan A, Subramanian PS. Early macular vessel density loss in acute ischemic optic neuropathy compared to papilledema: implications for pathogenesis. Transl Vis Sci Technol. 2018;7(5):10. doi:https://doi.org/10.1167/tvst.7.5.10.
- Al-Sheikh M, Akil H, Pfau M, Sadda SR. Swept-source OCT angiography imaging of the foveal avascular zone and macular capillary network density in diabetic retinopathy. Invest Ophthalmol Vis Sci. 2016;57(8):3907–3913. doi:https://doi.org/10.1167/iovs.16-19570.
- Coscas F, Sellam A, Glacet-Bernard A, Jung C, Goudot M, Miere A, et al. Normative data for vascular density in superficial and deep capillary plexuses of healthy adults assessed by optical coherence tomography angiography. Invest Ophthalmol Vis Sci. 2016;57(OCT):211–223. doi:https://doi.org/10.1167/iovs.15-18793.
- Durbin MK, An L, Shemonski ND, Soares M, Santos T, Lopes M, et al. Quantification of retinal microvascular density in optical coherence tomographic angiography images in diabetic retinopathy. JAMA Ophthalmol. 2017;135:370–376. doi:https://doi.org/10.1001/jamaophthalmol.2017.0080.
- Dolman PJ. Grading Severity and Activity in Thyroid Eye Disease. Ophthalmic Plast Reconstr Surg. Jul/Aug 2018: 34(4S Suppl 1): S34–S40.
- Mourits MP, Prummel MF, Wiersinga WM, Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ Ophthalmopathy. Clin Endocrinol (Oxf). Jul 1997;47(1):9–14. doi:https://doi.org/10.1046/j.1365-2265.1997.2331047.x.
- Dolman PJ, Rootman J. VISA classification for graves orbitopathy. Ophthalmic Plast Reconstr Surg. Sep-Oct. 2006;22(5):319–324. doi:https://doi.org/10.1097/01.iop.0000235499.34867.85.
- Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci, et al. European group on graves’ orbitopathy (EUGOGO). Consensus statement of the European Group on Graves’ orbitopathy (EUGOGO) on management of GO. Eur J Endocrinol. Mar 2008;158(3):273–285. doi:https://doi.org/10.1530/EJE-07-0666.
- Kraus MF, Potsaid B, Mayer MA, Bock R, Baumann B, Liu JJ, et al. Motion correction in optical coherence tomography volumes on a per A-scan basis using orthogonal scan patterns. Biomed Opt Express. 2012;Jun1(3):1182–1199. doi:https://doi.org/10.1364/BOE.3.001182.
- Battaglia Parodi M, Cicinelli MV, Rabiolo A, Pierro L, Bolognesi G, Bandello F. Vascular abnormalities in patients with Stargardt disease assessed with optical coherence tomography angiography. Br J Ophthalmol. Jun 2017;101:780–785. doi:https://doi.org/10.1136/bjophthalmol-2016-308869.
- Huang Y, Zhou L, Zhang Bao J, Cai T, Wang B, Li X, et al. Peripapillary and parafoveal vascular network assessment by optical coherence tomography angiography in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders. Br J Ophthalmol. 2019;103:789–796. doi:https://doi.org/10.1136/bjophthalmol-2018-312231.
- Tehrani JM, Mahdizad Z, Kasaei A, Fard MA. Early macular and peripapillary vasculature dropout in active thyroid eye disease. Graefes Arch Clin Exp Ophthalmol. 2019;257:2533–2540.
- Zhang T, Xiao W, Ye H, Chen R, Mao Y, Yang H. Peripapillary and macular vascular density in dysthyroid optic neuropathy: an optical coherence tomography angiography study. Invest Ophthalmol Vis Sci. 2019;60:1863–1869. doi:https://doi.org/10.1167/iovs.18-25941.
- Sayin O, Yeter V, Ariturk N. Optic disc, macula, and retinal nerve fiber layer measurements obtained by OCT in Thyroid-associated ophthalmopathy. J Ophthalmol. 2016;9452687.
- Chu CH, Lee JK, Keng HM, Chuang M, Lu C, Wang M, et al. Hyperthyroidism is associated with higher plasma endothelin-1 concentrations. Exp Biol Med. 2006;231:1040–1043.
- Salvatore S, Vingolo EM. Endothelin-1 role in the human eye: a review. J Ophthalmol. 2010;354645.
- Shortt AJ, Fulcher T, Conroy D. ocular ischemic syndrome in thyroid eye disease, confirmed using magnetic resonance angiography. Br J Ophthalmol. 2003;87:1302–1303. doi:https://doi.org/10.1136/bjo.87.10.1302.
- de Carlo TE, Romano A, Waheed NK, Duker JS. A review of optical coherence tomography angiography (OCTA). Int J Retin Vitr. 2015;1:5. doi:https://doi.org/10.1186/s40942-015-0005-8.
- Perez-Lopez M, Sales-Sanz M, Rebolleda G, Casas-Llera P, Gonzalez-Gordaliza C, Jarrin E, et al. Retrobulbar ocular blood flow changes after orbital decompression in Graves’ ophthalmopathy measured by color Doppler imaging. Invest Ophthalmol Vis Sci. 2011;52:5612–5617. doi:https://doi.org/10.1167/iovs.10-6907.
- Tsai C, Kau H, Kao S, Lin M, Hsu W, Liu J, et al. Pulsatile ocular blood flow in patients with Graves’ ophthalmopathy. Eye. 2005;19:159–162. doi:https://doi.org/10.1038/sj.eye.6701434.
- Abbott CJ, Choe TE, Lusardi TA, Burgoyne CF, Wang L, Forture B. Evaluation of retinal nerve fiber layer thickness and axonal transport 1 and 2 weeks after 8 hours of acute intraocular pressure elevation in rats. Invest Ophthalmol Vis Sci. 2014;55:674–687. doi:https://doi.org/10.1167/iovs.13-12811.
- Rajabi MT, Ojani M, Esfahani HR, Tabatabaei SZ, Rajabi MB, Hosseini AA. Correlation of peripapillary nerve fiber layer thickness with visual outcomes after decompression surgery in subclinical and clinical thyroid-related compressive optic neuropathy. J Curr Ophthalmol. 2019;31:86–91. doi:https://doi.org/10.1016/j.joco.2018.11.003.